Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Omnibus spending package

This article was originally published in The Gray Sheet

Executive Summary

President Clinton signs fiscal 2000 Omnibus Consolidated Appropriations Act at a White House ceremony Nov. 29. HR 3194 includes $16 bil. over five years to restore some planned BBA 1997 cuts to Medicare providers and Medicare+Choice plans. The legislation was adopted by the House Nov. 18 and the Senate on Nov. 19. In his remarks, Clinton highlighted increased investment in biomedical research, mental health and pediatric training, including a $2.3 bil. increase to $17.9 bil. for the National Institutes of Health. Clinton noted that passage of a Patients' Bill of Rights and Medicare reform, including a voluntary prescription drug benefit, are among the Administration's priorities for next year

Latest Headlines
See All
UsernamePublicRestriction

Register

MT012679

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel